SLC1A2 and Alzheimer disease: Many studies have illustrated that the expression of glutamate transporter-1 (GLT-1), as the primary astrocyte glutamate transporter, is significantly decreased in patients with AD, suggesting that glutamate-mediated excitotoxicity may be involved in the pathogenesis of AD [37].